Ania B. Koziell

Guy's And St Thomas' NHS Trust
London, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 30 publications

Polygenic Risk Scores and HLA Class II Variants are Biomarkers of Corticosteroid Response in Childhood Nephrotic Syndrome.

Polygenic Risk Scores and HLA Class II Variants are Biomarkers of Corticosteroid Response in Childhood Nephrotic Syndrome.

Journal: medRxiv : the preprint server for health sciences

Published: September 19, 2025

Polygenic risk scores and HLA class II variants are biomarkers of corticosteroid response in childhood nephrotic syndrome.

Polygenic risk scores and HLA class II variants are biomarkers of corticosteroid response in childhood nephrotic syndrome.

Journal: Kidney international

Published: August 06, 2025

Modelling APOL1-mediated kidney inflammation and fibrosis using a partially reprogrammed urine-derived SIX2-positive renal progenitor cell line.

Modelling APOL1-mediated kidney inflammation and fibrosis using a partially reprogrammed urine-derived SIX2-positive renal progenitor cell line.

Journal: Stem cell research & therapy

Published: July 27, 2025

Comparative risk of end-stage renal disease, myocardial infarction and stroke in young and older onset diabetes in UK Biobank.

Comparative risk of end-stage renal disease, myocardial infarction and stroke in young and older onset diabetes in UK Biobank.

Journal: Scientific reports

Published: January 27, 2025

National Unified Renal Translational Research Enterprise: Idiopathic Nephrotic Syndrome (NURTuRE-INS) study.

National Unified Renal Translational Research Enterprise: Idiopathic Nephrotic Syndrome (NURTuRE-INS) study.

Journal: Clinical kidney journal

Published: January 29, 2024

Correction: Consensus statement on standards and guidelines for the molecular diagnostics of Alport syndrome: refining the ACMG criteria.

Correction: Consensus statement on standards and guidelines for the molecular diagnostics of Alport syndrome: refining the ACMG criteria.

Journal: European journal of human genetics : EJHG

Published: January 31, 2023

Rare heterozygous variants in paediatric steroid resistant nephrotic syndrome - a population-based analysis of their significance.

Rare heterozygous variants in paediatric steroid resistant nephrotic syndrome - a population-based analysis of their significance.

Journal: Scientific reports

Published: November 25, 2022

Shared genetic risk across different presentations of gene test-negative idiopathic nephrotic syndrome.

Shared genetic risk across different presentations of gene test-negative idiopathic nephrotic syndrome.

Journal: Pediatric nephrology (Berlin, Germany)

Published: August 03, 2022

Economic Evaluation of Using Daily Prednisolone versus Placebo at the Time of an Upper Respiratory Tract Infection for the Management of Children with Steroid-Sensitive Nephrotic Syndrome: A Model-Based Analysis.

Economic Evaluation of Using Daily Prednisolone versus Placebo at the Time of an Upper Respiratory Tract Infection for the Management of Children with Steroid-Sensitive Nephrotic Syndrome: A Model-Based Analysis.

Journal: PharmacoEconomics - open

Published: March 28, 2022

Daily low-dose prednisolone to prevent relapse of steroid-sensitive nephrotic syndrome in children with an upper respiratory tract infection: PREDNOS2 RCT.

Daily low-dose prednisolone to prevent relapse of steroid-sensitive nephrotic syndrome in children with an upper respiratory tract infection: PREDNOS2 RCT.

Journal: Health technology assessment (Winchester, England)

Published: January 21, 2022

Guidelines for Genetic Testing and Management of Alport Syndrome.

Guidelines for Genetic Testing and Management of Alport Syndrome.

Journal: Clinical journal of the American Society of Nephrology : CJASN

Published: December 21, 2021

Evaluation of Daily Low-Dose Prednisolone During Upper Respiratory Tract Infection to Prevent Relapse in Children With Relapsing Steroid-Sensitive Nephrotic Syndrome: The PREDNOS 2 Randomized Clinical Trial.

Evaluation of Daily Low-Dose Prednisolone During Upper Respiratory Tract Infection to Prevent Relapse in Children With Relapsing Steroid-Sensitive Nephrotic Syndrome: The PREDNOS 2 Randomized Clinical Trial.

Journal: JAMA pediatrics

Published: December 20, 2021

Showing 1-12 of 30

Last Updated: 09/26/2026